ZacksJun 24, 2026, 12:00 AMnasdaq
DaVita HealthCare (DVA) Ascends While Market Falls: Some Facts to Note
The latest trading day saw DaVita HealthCare (DVA) settling at $213.04, representing a +1% change from its previous close.
Open articleZacksJun 24, 2026, 12:00 AMnasdaq
DaVita Stock Benefits From Expanding Community-Based Kidney Care
DVA is expanding kidney care through outpatient, home-centered and value-based programs while investing in AI-enabled scheduling.
Open articleZacksJun 23, 2026, 12:00 AMnasdaq
DVA vs. FMS: Which Dialysis Leader Is Better Positioned Now?
DaVita and Fresenius Medical Care are taking different paths in kidney care, but which stock offers stronger upside now? Let's dive in.
Open articleZacksJun 22, 2026, 12:00 AMnasdaq
3 Medical Stocks to Bet on Amid Market Optimism Following SpaceX IPO
Medical stocks like Centene, DaVita and BrightSpring could rally as SpaceX IPO-fueled market optimism lifts broader sector sentiment.
Open articleZacksJun 22, 2026, 12:00 AMnasdaq
Best Growth Stocks to Buy for June 22nd
HRB, DVA and PBI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 22nd, 2026.
Open articleZacksJun 22, 2026, 12:00 AMnasdaq
Zacks.com featured highlights include Murphy, DaVita, Hewlett Packard and Vishay
Murphy, DaVita, Hewlett Packard and Vishay have been highlighted in this Screen of The Week article.
Open articleZacksJun 18, 2026, 12:00 AMnasdaq
DaVita HealthCare (DVA) Stock Dips While Market Gains: Key Facts
DaVita HealthCare (DVA) closed the most recent trading day at $207.91, moving 1.27% from the previous trading session.
Open articleZacksJun 17, 2026, 12:00 AMnasdaq
DaVita Expands Specialized Care Beyond Acute Settings Through IKC
DVA is expanding kidney care beyond hospitals with IKC, digital tools and AI to improve coordination, lower costs and support patients.
Open articleThe Motley FoolJun 15, 2026, 12:00 AMnasdaq
DaVita vs. Encompass Health: Which Healthcare Stock Is a Better Buy in 2026?
Key PointsDaVita operates more than 3,200 dialysis centers globally, serving roughly 295,000 patients with a dominant market share in kidney care.
Open articleZacksJun 15, 2026, 12:00 AMnasdaq
Best Growth Stocks to Buy for June 15th
DVA, FIVE, and PBI it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 15, 2026.
Open articleZacksJun 11, 2026, 12:00 AMnasdaq
DaVita HealthCare (DVA) Exceeds Market Returns: Some Facts to Consider
In the most recent trading session, DaVita HealthCare (DVA) closed at $203.83, indicating a +2.66% shift from the previous trading day.
Open articleZacksJun 11, 2026, 12:00 AMnasdaq
DaVita HealthCare (DVA) Moves to Strong Buy: Rationale Behind the Upgrade
DaVita HealthCare (DVA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Open article